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Abstract 
Cryptosporidiosis is a diarrhoeal illness caused by the protozoan parasite 
Cryptosporidium. In Australia, very little is known about the epidemiology of 
cryptosporidiosis in Aboriginal peoples. The present study analysed long-term 
cryptosporidiosis patterns across Western Australia (WA) (2001–2012), combined with 
genotyping and subtyping data at the 18S and glycoprotein 60 (gp60) loci respectively. 
Comparison of cryptosporidiosis notifications between Aboriginal and non-Aboriginal people 
in WA, revealed that notification rates among Aboriginal people were up to 50 times higher 
compared to non-Aboriginal people, highlighting the burden of the disease in this population. 
More than 90% of notifications were in Aboriginal children aged 00-04 years, who had a 
notification rate 20.5 times higher than non-Aboriginal children in the same age group. 
Cryptosporidium hominis was the predominant species infecting both Aboriginal and non-
Aboriginal people.  However, Aboriginal people were mainly infected with the C. hominis 
IdA15G1 subtype, whereas non-Aboriginal people were predominantly infected with the 
IbA10G2 subtype. To control cryptosporidiosis in Aboriginal populations in Australia, 
effective health interventions/promotions need to be a priority for public health research and 
action. 
 
Keywords: Cryptosporidium; Aboriginal; Non-Aboriginal; Western Australia; gp60 
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1.0 Introduction 
 
Cryptosporidium is a protozoan parasite of medical and veterinary importance that 
causes gastroenteritis in a variety of vertebrate hosts (Xiao, 2010). In addition to diarrhea, 
symptoms associated with cryptosporidiosis include vomiting, nausea, lack of appetite and 
cramps (Chalmers and Davies, 2010). Malnutrition, which impairs cellular immunity, is an 
important risk factor for cryptosporidiosis (Gendrel et al., 2003) and Cryptosporidium 
infection in children is also associated with persistent growth retardation and cognitive 
deficits (Guerrant et al., 1999; Mondal et al., 2009). Currently 33 species of Cryptosporidium 
are recognized as valid and of these, C. hominis and C. parvum account for more than 90% of 
human cases of cryptosporidiosis worldwide, infecting 8-10 million people per year (Xiao, 
2010; Jezkova et al., 2016; Ryan et al., 2016; Seeber and Steinfelder, 2016).   
Human cryptosporidiosis is a notifiable disease in several, mainly European countries 
(ECDC, 2014).  In Australia, the National Notifiable Diseases Surveillance System (NNDSS) 
was established in 1990, under the auspices of the Communicable Diseases Network 
Australia and in 2001, cryptosporidiosis was listed as a national notifiable disease (Blumer et 
al., 2003).  At the time of study, only confirmed cases (based on microscopy or PCR) are 
reported to the NNDSS. However, molecular identification of Cryptosporidium species is not 
routinely carried out, and therefore the Cryptosporidium species responsible for the infections 
reported to the NNDSS are generally unknown.  
To date, in humans in Australia, C. hominis, C. parvum, C. meleagridis, C. fayeri, C. 
andersoni, C. bovis, C. cuniculus, a novel Cryptosporidium species most closely related to C. 
wrairi and the Cryptosporidium mink genotype have been reported (Morgan at al., 1997; 
Morgan et al., 1998;  Gasser et al., 2004; Chalmers et al., 2005; Jex et al., 2007; Ng et al., 
2008; Jex et al., 2008; Alagappan et al., 2008; Pangasa et al., 2009; Waldron et al., 2009; Ng 
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et al., 2010a; 2010b; Waldron et al., 2010; Power et al., 2011; Waldron et al., 2011a; Ng et 
al., 2012; Jex et al., 2012; Ng-Hublin et al., 2013; Sari et al., 2013 unpublished - KF279538; 
Yang et al., 2013; Koehler et al., 2013; Koehler et al., 2014a; 2014b; Ebner et al., 2015; Ng-
Hublin et al., 2015).  
Very little is known about cryptosporidiosis in Aboriginal people, although previous 
studies have reported high rates of cryptosporidiosis in Aboriginal children (Assadamongkol  
et al., 1992; Lal et al., 2015a; 2015b). The present study therefore aimed to provide insights 
into the prevalence, disease patterns of cryptosporidiosis and species and subtypes of 
Cryptosporidium in Aboriginal and non-Aboriginal people in Western Australia (WA), from 
the first full year of reporting in 2002 through to 2012.  
 
2. Material and Methods 
 
2.1 Case definition 
 
The Australian case definition for cryptosporidiosis notification, which is also 
adopted by WA, requires laboratory definitive evidence through the detection of 
Cryptosporidium oocysts (NNDSS, 2016).  
 
2.2 Data source and extraction 
 
Cryptosporidiosis notification data used in the present study were obtained from the 
Western Australian Notifiable Infectious Disease Database (WANIDD) by the data 
custodian, the Communicable Disease Control Directorate (CDCD) at the WA Department of 
Health. The WA surveillance system relies on mandatory reporting of notifiable diseases by 
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laboratories and medical practitioners. WANIDD, is an intranet-based real-time application 
with notifications from laboratories uploaded electronically and notifications from medical 
practitioners added manually.  
  WANIDD data from January 2002 to December 2012 were extracted and included in 
the present study. The data was saved in Microsoft Excel de-identified through removal of 
case name, address and date of birth, under Murdoch Human Ethics approval number 
2012/208 and the WA Department of Health Ethics approval number 2009/48.  The ODOO is 
defined as the ‘true’ date of onset provided by the notifying doctor or obtained during case 
follow-up, the date of specimen collection for laboratory notified cases, and when neither of 
these dates is available, the date of notification by the doctor or laboratory, or the date of 
receipt of notification, whichever is earliest. 
Variables exported from WANIDD included public health unit (PHU), sex, country of 
birth, Aboriginal status, age, travel history, location where infection was acquired and 
hospitalization. Additional information such as clinical symptoms, duration of diarrhea and 
the infecting Cryptosporidium species based on molecular typing data (when available), were 
included in variables exported.  
 
2.3 Molecular typing 
 
Molecular typing was conducted on a total of 324 Cryptosporidium-positive human 
faecal samples provided by WA clinical pathology laboratories. These samples were matched 
to the basic demographic data of cases from WANIDD. Molecular genotyping was carried 
out on isolates with ODOO from 2005 to 2008 and have been detailed in two previous studies 
Ng et al. (2010a) (n = 198) and Ng et al. (2010b) (n = 42). Molecular genotyping for the 
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remaining 84 samples were carried out from June 2010 to December 2012 as part of the 
present study. 
Total DNA was extracted using a QIAmp DNA Stool Kit (Qiagen, Germany). Initial 
genotyping of the samples was carried out by PCR-RFLP and sequencing of an 830 bp 
fragment of the Cryptosporidium 18S rRNA gene as described by Xiao et al. (2001). For 
samples that failed to amplify or produced ambiguous banding patterns, a two-step nested 
PCR and sequencing of 540 bp of the 18S rRNA gene was carried out (Ryan et al., 2003). 
Samples that were positive for C. hominis and C. parvum were subtyped at the glycoprotein 
60 (gp60) gene using a two-step nested PCR that amplifies an 830 bp fragment (Strong et al., 
2000; Sulaiman et al., 2005). Secondary PCR products were purified and sequenced as 
described by Ng et al. (2006). 
 
2.4 Data analysis 
 
Statistical analyses were conducted using Microsoft Excel 2010 and OpenEpi version 
3.01 (http://openepi.com/v37/Menu/OE_Menu.htm) and STATA 13. Notification rates were 
calculated using annual census population data available through the Rates Calculator 
software (Department of Health, WA) and age standardised to the Australian population.  
Notification Rate Ratios were calculated by dividing the notification rate in Aboriginal 
people by the notification rate in non-Aboriginal people.  WA population estimates for public 
health unit (PHU) areas, year, sex, age and Aboriginality status was used to calculate 
notification rates and described as number of notified cases per 100,000 populations/year. 
Public Health Units in Western Australia are divided into different health administrative 
regions –Metropolitan (North and South), Kimberley, Pilbara and Goldfields region 
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(classified as remote) and the Midwest, Wheatbelt, South West and Great Southern (classified 
as rural). 
 
3. Results 
 
A total of 2,988 cryptosporidiosis cases, with an average notification rate of 12.7 
cases/100,000 population, were reported in WA during the 11-year period from January 2002 
to December 2012. Individuals that were not residents of WA accounted for 17 of the cases 
notified during this period, of which three cases were Aboriginal people, nine were non-
Aboriginal and the Aboriginality status for five of the remaining cases was not recorded.  
 
3.1 Cryptosporidium notification rates in Aboriginal and non-Aboriginal people 
 
Of the 2,988 cryptosporidiosis notifications, 24.6% (734/2,988) were Aboriginal 
people, 53.1% (1,585/2,988) were non-Aboriginal people and Aboriginal status was not 
recorded for 22.4% of cases. Notification rates in Aboriginal and non-Aboriginal people over 
the 11-year period ranged from 42.9-135.8 and 2.4-20.4 per 100,000 population per year, 
respectively (Table 1). The highest difference in notification rate between Aboriginal people 
and non-Aboriginal people occurred in 2004, with a notification rate ratio of 53.1 and the 
lowest in 2007 with a notification rate ratio of 5.6 (Table 1).  
A bimodal distribution of notifications was observed for non-Aboriginal age groups, 
with peaks in the 0-4 years age group (33.3% of cases, notification rate = 36.5 notifications 
per 100,000/year)) and the 30-34 year age group (9% of cases, notification rate = 8.7 
notifications per 100,000/year) was observed. In contrast, there was a unimodal distribution 
of notifications for age groups in Aboriginal people, with 93.2% of cases reported in the 0-4 
years age group (749.6 cases per100,000/year) (Fig. 1, Table 2). The notification rate ratio in 
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the 0-4 years age group in Aboriginal and non-Aboriginal people was 20.5 (Table 2). Within 
the 0-4 years age group, Aboriginal children ≤ 1 years of age had the highest average rate at 
1,549 cases/100,000 population, followed by 2 year olds with a rate of 564 cases/100,000 
population. Similarly, non-Aboriginal children in the 0-4 years age group with the highest 
number of notification rates were children ≤ 1 years of age and at 2 years of age with average 
rates of 41 cases/100,000 population. 
Aboriginal people had higher notification rate ratios compared to non-Aboriginal 
people in the 45-49 (notification rate ratio = 4.8), 50-54 (notification rate ratio = 3.7), 55-59 
(notification rate ratio = 5.8) and 60-64 (notification rate ratio = 4.9) age groups (Table 2). 
Male Aboriginal people had a higher notifications rate (95.3 per 100,000 population, 
notification rate ratio = 14.7) compared to male non-Aboriginal people (7.5 per 100,000 
population). Similarly, notification rates among female Aboriginal people were higher (90.5 
per 100,000 population, notification rate ratio = 12.1) compared to female non-Aboriginal 
people (7.5 per 100,000 population).  
Rates of cryptosporidiosis notifications were higher among Aboriginal people 
compared to non-Aboriginal people across all PHUs, ranging from 11.9-246.6 per 100,000 
population (Table 3). The remote regions (Goldfields, Kimberley and Pilbara), had the 
highest average number of cases notified among the Aboriginal people, particularly in the 
Kimberley, with an average of 38.5 cases notified each year between 2002-2012, at a rate of 
246.6 per 100,000 per year (Table 3). Among non-Aboriginal people, the highest number of 
notifications was reported from the Metropolitan region (91.5 per year; notification rate = 5.6 
per 100,000 per year), while the highest notification rate was in the Kimberley (notification 
rate = 51.2 per 100,000 per year (Table 3).  
Hospitalisation data were available for 55% (1,268/2,320) of cases with recorded 
Aboriginal status, comprising 251 Aboriginal people and 1,017 non-Aboriginal people. A 
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total of 244 cases of cryptosporidiosis were hospitalised between 2002 and 2012. A 
significantly (P<0.01) higher proportion of Aboriginal people were hospitalised (53% 
133/251) compared to non-Aboriginal people (10.8% 110/1,017). Children aged 0-4 years 
comprised the majority of both Aboriginal and non-Aboriginal cases hospitalised, at 89.5% 
(119/133) and 34.2% (38/111) respectively.  
 
3.2 Molecular Epidemiology 
 
Data for molecular analyses carried out were available for the specimens tested from 
April 2005 to January 2008 and from June 2010 to December 2012 (n = 324 cases), with 
Aboriginal status recorded in only 290 of these cases. In total, C. hominis was identified in 
259/324 (79.9%) cases, C. parvum in 54 (16.6%) and C. meleagridis in 10 (3.1%) cases, with 
one case (0.3%) identified with a mixed infection of C. meleagridis, Cryptosporidium Mink 
genotype and an unknown Cryptosporidium genotype (Table 4). The latter two genotypes 
have been previously analysed in more depth (Ng-Hublin et al., 2013).  
Of the cases identified with C. hominis (n = 259), 58.7% (152/259) were non-
Aboriginal people, 32% (83/259) were Aboriginal people and the status of 9.3% were 
unknown (Table 4). However, Aboriginal people were 1.3 times more at risk (RR 1.3; 95% 
CI, 1.21-1.44, p < 0.05) than non-Aboriginal people of being infected with C. hominis. Only 
a small proportion of Aboriginal people (2.4%; 2/85) were diagnosed with C. parvum, with 
97.6% (83/85) of cases diagnosed with C. hominis (Table 4). Non-Aboriginal people were 8.7 
times more likely to be infected with C. parvum compared to Aboriginal people (RR 8.7; 
95% CI, 2.16-35.16, p < 0.05). All cases infected with C. meleagridis were non-Aboriginal 
people. Thus, zoonotic Cryptosporidium (C. parvum, C. meleagridis and the mink genotype) 
were identified in 25.8% (53/205) of non-Aboriginal people. 
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The most common C. hominis subtype identified in Aboriginal people was the 
IdA15G1 subtype (59%; 49/83), followed by IgA17 (30.1%; 25/83) and IbA10G2 (8.4%; 
7/83). In non-Aboriginal people, C. hominis IbA10G2 was the most common (61.8%; 
94/152), followed by IgA17 (16.4%; 25/152) and IdA15G1 (15.1%; 23/152) (Table 4). 
Aboriginal people were 3.9 times more likely to be infected with the C. hominis IdA15G1 
subtype (RR 3.90; 95% CI, 2.57-5.92, p < 0.05) and 1.8 times more likely to be infected with 
IgA17 (RR 1.8; 95%CI, 1.13-2.98, p < 0.05) compared to non-Aboriginal people. Compared 
to Aboriginal people, non-Aboriginal people were 7.2 times more likely to be infected with 
the IbA10G2 subtype (RR 7.24; 95%CI, 3.52-14.87, p < 0.05). The two most common C. 
parvum subtypes identified in non-Aboriginal people were the IIaA17G2R1 subtype (21%; 
9/42) and IIaA18G3R1 (66.6%; 28/42).  
The majority of typed cases from Aboriginal people came from remote areas, 
particularly the Kimberley. Of the 113 typed cases from remote areas, 70.8% (80/113) were 
from the Kimberley, and Aboriginal people consisted of 67.5% (54/80) of these. Very few 
typed Aboriginal cases came from metropolitan Perth (2% - 2/101) compared to Non-
Aboriginal cases (98% - 99/101). Similarly, 87.1% (954/62) of non-Aboriginal cases came 
from rural areas compared to Aboriginal people (12.9% - 8/62). 
 Distribution of gp60 subtypes indicated that in the remote regions of WA, the 
majority (60.8% - 45/74) of infections in Aboriginal people were attributed to the IdA15G1 
subtype, followed by the IgA17 subtype (29.7% - 22/74), whereas in non-Aboriginal people, 
infection was attributed to the IbA10G2 subtype (46.2% - 18/39) and the IdA15G1 subtype 
(30.8% - 12/39) (Table 5). In the rural regions of WA, 37.5% (3/8) of Aboriginal people were 
infected with the IdA15G1 subtype, followed by the IbA10G2 and IgA17 subtypes in 25% 
(2/8) of cases each. Non-Aboriginal people were mainly infected with the IbA10G2 subtype, 
(22.2% - 12/54), followed by the IgA17 and IdA15G1 subtypes in 16.7% (9/54) and 14.8% 
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(8/54) of cases respectively (Table 5). In the Metropolitan area, the IbA10G2 subtype was 
identified in 63.3% (62/99) of non-Aboriginal people, followed by the C. parvum 
IIaA18G3R1 subtype (13.3% - 13/99) and IgA17 (11.1% - 11/99) (Table 5). Only two 
Aboriginal people were identified from the Metropolitan area and the IbA10G2 and IgA17 
subtypes were identified in a case each (Table 5). 
Molecular genotyping data were available for 168 hospitalised cases, for which 
Aboriginal status was known. Aboriginal people comprised 27/168 of cases, of which 63.0% 
(17/27) were hospitalised, whilst non-Aboriginal people comprised 141/168 of cases, of 
which 19.9% (28/141) were hospitalised. All 17 hospitalised Aboriginal people were infected 
with C. hominis and 16 of these were children (aged 0-4 years).  The IdA15G1 subtype was 
identified in 10/17 cases, the IbA10G2 and IgA17 subtypes identified in three cases each and 
the IeA11G3T3 subtype identified in one case. Cryptosporidium hominis was detected in 
15/28 hospitalised non-Aboriginal people, followed by C. parvum in 11/28 cases and C. 
meleagridis in two cases, one of which was a mixed infection with Mink genotype. The C. 
hominis IbA10G2 subtype was the most common (11/15), followed by the IdA15G1 subtype 
in two cases and the IfA12G1 subtype in one case. For cases infected with C. parvum, the 
IIaA18G3R1 subtype was the most common subtype, identified in eight cases, followed by 
the IIaA17G2R1 subtype in two cases and the IIaA15G2R1 subtype in one case. 
 
4. Discussion 
 
Rates of reported cryptosporidiosis in Australia are higher than many comparable 
developed countries (Lal et al., 2015a), with an average rate of 12.5 cases/100,000 
population/year across Australia between 2001-2016 (NNDSS, 2016). However, the actual 
number of cryptosporidiosis cases in Australia and worldwide is likely to be much higher as 
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routine surveillance systems detect only a small fraction of the pathogen infections that occur 
in the community because: (1) it is estimated that less than 10% of individuals with 
gastroenteritis visit their local doctor, and of these, less than 10% have a faecal specimen 
collected (2) not all individuals presenting with gastroenteritis will have faecal samples tested 
for microorganisms and (3) identification of Cryptosporidium and other pathogens via 
microscopy lacks specificity and sensitivity) (cf. Ryan et al., 2017). For example, a national 
survey of gastroenteritis in Australia in 2002, suggested a ratio of about 500 community cases 
to one notified (Hall et al., 2006). A more recent study reported that in 2010 alone, 
cryptosporidiosis was estimated to be responsible for 195,495 cases of acute gastroenteritis 
(AGE) and 333 disability-adjusted life years (DALYs) in Australia (Gibney et al., 2014).  
Under-reporting of cryptosporidiosis is even more pronounced in Aboriginal 
communities due to the difficulty they have accessing health services. For example, in 2008, 
the National Aboriginal and Torres Strait Islander Social Survey (NATSISS) found that about 
26% of Indigenous people aged 15 and over living in non-remote areas, had difficulty 
accessing health services (AIHW, 2011); in contrast, only 2.6% of the general population had 
difficulty (ABS, 2012). The main reasons cited were long waiting times, services not being 
available when needed, difficulties with transport and health-care costs. Less commonly 
reported reasons included lack of engagement, fear of discrimination and poor treatment 
arising from previous experiences, and the lack of culturally appropriate services (AIHW, 
2011).  
The disparity of health status between Aboriginal people and non-Aboriginal people 
in Australia has been well documented, with diarrhoea caused by gastrointestinal parasites 
recognised as issues of major importance in Aboriginal populations (Gracey and Cullinane, 
2003; Bramley et al., 2004; Holt et al., 2010; Hotez, 2014; Shield et al., 2015). As the 
majority of Aboriginal people reside in remote areas, the significantly higher 
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cryptosporidiosis notification rates in Aboriginal people compared to non-Aboriginal people 
(up to 50 times higher), especially in children 0-4 years of age, is likely due to factors 
associated with remote living such as poor socioeconomic status and household conditions, as 
well as limited access to nutritious food, potable drinking water, adequate sewage and solid 
waste disposals; all of which facilitate the faecal-oral transmission of Cryptosporidium, thus 
increasing the risk of infection (Bailie et al., 2004, Bailie et al., 2010, McDonald and Bailie, 
2010, Becker et al., 2015).   
Among both Aboriginal and non-Aboriginal people, the largest number of 
notifications occurred in children aged 0-4 years, in particular those aged 1 year or less, 
consistent with studies worldwide (Ryan et al., 2016; Kotloff et al., 2016). The bimodal age 
related pattern observed in non-Aboriginal cases is consistent with the general trend observed 
in previous studies in WA, other states in Australia, as well as in the US, Canada and UK 
(Laupland and Church, 2005; Ng et al., 2010b; Yoder and Beach, 2010; Chalmers et al., 
2011; Kent et al., 2011; Waldron et al., 2011a). The high cryptosporidiosis rates, particularly 
in females in the 20-39 years age group, has been attributed to the occurrence of transmission 
between children and their caregivers (family members, childcare staff, household contact), 
possibly through child minding and nappy changing activities (Robertson et al., 2002; Hunter 
et al., 2004).  
 Aboriginal people comprise 30-40% of the population in rural and remote areas, in 
comparison to just 1.5% of the population in metropolitan areas, which may partly explain 
the increased rates of cryptosporidiosis cases among Aboriginal people in the remote regions 
of WA, particularly in the Kimberley. Notifications were highest during the Kimberley wet 
season (data not shown), which occurs from November to April (late spring to autumn), when 
there is flooding and swimming in natural water holes or catchment is a common practice, 
resulting in increased potential for transmission.  
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The predominantly anthroponotically transmitted C. hominis was the most common 
species identified among Aboriginal and non-Aboriginal people, suggesting person to person 
transmission. A higher proportion of zoonotic Cryptosporidium species were detected in non-
Aboriginal cases (25.8% v 2.5%), with C. parvum and C. meleagridis identified mainly from 
the metropolitan area, but also from rural regions (e.g. South West and Great Southern), 
where there is greater density of livestock. Four different C. parvum subtypes were identified 
from cases in this region; the IIaA17G2R1 and IIaA18G3R1, which have previously been 
identified from cattle in the South West region (Ng et al., 2011) and the IIaA19G4R1 and 
IIaA21G2R1 subtype. There have been no previous reports of the C. parvum IIaA19G4R1 
and IIaA21G2R1 in livestock in WA, although these subtypes have been identified from 
cattle in New South Wales (NSW) (Ng et al., 2008). These and the other C. parvum IIa 
subtypes identified in the present study, particularly the IIaA18G3R1 subtype, are common 
C. parvum subtypes identified in humans and cattle in Australia (Jex et al., 2007; Jex et al., 
2008; Ng et al., 2008; O’Brien et al., 2008; Waldron et al., 2009; Ng et al., 2011; Ng et al., 
2012). In the present study, the C. parvum IIdA15G1 subtype was identified in one case, 
which has been reported in buffalo from the Northern Territory (Zahedi et al., 2016a). As not 
all C. parvum and C. meleagridis infections are attributed to zoonotic transmission, it is 
difficult to deduce whether the source of these infections were zoonotic or anthroponotic, 
without carrying out extensive molecular genotyping of both humans and animals in the 
regions. However, the identification of these C. parvum genotypes in both humans and 
livestock (Xiao, 2010), indicates that animals may play a role in the dissemination of 
Cryptosporidium oocysts. Therefore, further investigation should be carried to determine the 
extent of zoonoses and the risk to public health as well as to catchment water quality in the 
area. 
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  Aboriginal people were mainly infected with the C. hominis IdA15G1 subtype (59%) 
whereas non-Aboriginal people, were predominantly infected with the IbA10G2 subtype 
(61.8%). The IdA15G1 subtype was previously identified as the most common subtype in 
WA (Ng et al., 2010) and has also been identified in NSW and Victoria (VIC) (Jex et al., 
2007; Ng et al., 2008). It has been responsible for waterborne outbreaks in the U.S. (Feng et 
al., 2014). The IbA10G2 subtype is recognised as a major cause of sporadic cryptosporidiosis 
in WA, VIC, South Australia (SA), and NSW (Jex et al., 2007; Jex et al., 2008; Waldron et 
al., 2009; Ng et al., 2010; Waldron et al., 2011a), is highly virulent and has been associated 
with numerous waterborne cryptosporidiosis outbreaks in Australia (Ng et al., 2010; Mayne 
et al., 2011; Waldron et al., 2011b; Ng-Hublin et al., 2013) and worldwide (cf. Li et al. 2013).  
 The identification of distinct C. hominis gp60 subtypes circulating among Aboriginal 
and non-Aboriginal populations highlights the unique endemicity of cryptosporidiosis in 
Aboriginal people. Due to low numbers of cases from Aboriginal people genotyped from 
other regions in WA, it is difficult to ascertain from this study, whether this endemicity of the 
C. hominis IdA15G1 subtype is unique to the Kimberley area, as direct comparisons could 
not be made in the metropolitan or other rural or remote regions. This finding however, 
provides an avenue for more focussed public health attention, better tracking of sources of 
infection and implementation of intervention measures to prevent transmission of the disease 
and warrants further investigations for a better understanding of the gp60 subtypes circulating 
among the populations and communities of Aboriginal and non-Aboriginal people in the 
Kimberley and other areas in WA.  
 Overall, the findings from the present study shows that the risk of cryptosporidiosis in 
Aboriginal people, especially those < 5 years of age is disproportionately greater than in non-
Aboriginal people, with the risk of the disease increasing with remoteness in WA. The 
predominance of C. hominis infections in both Aboriginal and non-Aboriginal people 
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indicates that the main transmission route of the disease is person to person; however, 
infection with distinct subtypes within the population suggests that the source of infection 
and transmission may differ. Factors associated with remote living such as poverty, access to 
nutritious food and sanitation resources that may impede the transmission of 
Cryptosporidium, are likely the underlying factor for the disparities observed in the present 
study. More focussed attention on interventions for disease control that includes handwashing 
with soap and water, sanitation and hygiene promotion, are most likely to reduce diarrhoeal 
illness, especially in children (McDonald et al., 2008) and are currently being carried out by 
environmental health practitioners working in Aboriginal communities in remote and rural 
areas http://www.public.health.wa.gov.au/2/1395/2/aboriginal_health.pm.  The importance of 
zoonotic transmission of cryptosporidiosis in WA however should not be discounted, 
particularly in light of the identification of C. hominis in kangaroos in Australia (Zhaedi et 
al., 2016b) and in cattle in New Zealand (Abeywardena et al., 2012). Further studies and 
molecular genotyping involving larger human, livestock and wildlife populations, particularly 
in livestock dense areas, as well as animals in Aboriginal communities, should be carried out 
to examine the extent of zoonoses in these communities.  
 Limitations of the present study include the use of passive surveillance data, which is 
subjected to under-reporting especially of asymptomatic cases (Lal et al., 2015b). Molecular 
data was also not available for every case analysed and specimens genotyped were sent from 
various pathology laboratories from different regions in WA, depending on whether adequate 
amount for analysis was available, which did not allow for standardisation of sample sizes for 
cross regional comparisons. However, the use of molecular data to complement existing 
surveillance data was one of the highlights of the present study, as it provided supporting 
evidence, and a better explanation and understanding of the surveillance data. Molecular 
surveillance should be routinely conducted for a better understanding of cryptosporidiosis 
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epidemiology in WA and across Australia, to allow for better detection and more targeted 
public health interventions.  
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Fig. 1. Comparison of number of cryptosporidiosis cases notified between Aboriginal people 
and non-Aboriginal people by age groups.  
 
 
 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
29 
 
  
 
Fig. 1  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
30 
 
Table 1.  
The annual number, notification rate, NR (notifications per 100,000/year) and notification 
rate ratio (NRR) of cryptosporidiosis notification in Aboriginal and non-Aboriginal people in 
Western Australia (2002-2012).  
 
Year Aboriginal people Non-Aboriginal people NRR 
Number NR Numbers NR 
2002 62 92.8 45 2.4 38.7 
2003 92 135.8 130 6.9 19.7 
2004 51 74.3 27 1.4 53.1 
2005 93 133.6 67 3.4 39.3 
2006 61 86.1 148 7.4 11.6 
2007 82 114.2 414 20.4 5.6 
2008 60 82.3 83 4 20.6 
2009 66 89.4 113 5.2 17.2 
2010 37 49.3 89 4 12.3 
2011 97 127.8 343 15.1 8.5 
2012 33 42.9 126 5.4 7.9 
Total 734  1,585   
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Table 2.  
The age distribution, notification rate, NR (notifications per 100,00/year) and notification 
rate ratio (NRR) of cryptosporidiosis notification in Aboriginal and non-Aboriginal people in 
Western Australia (2002-2012). 
 
Age 
Group 
Aboriginal 
(Aborg) 
Non-Aborginal 
(Non-Aborg) 
NRR 
Aborg:Non-Aborg Non-Aborg: Aborg 
0-4 749.6 36.5 20.5 0.0 
5-9 15.5 12.2 1.3 0.8 
10-14 3.2 5 0.6 1.6 
15-19 3.6 3.1 1.2 0.9 
20-24 7 6.3 1.1 0.9 
25-29 6.4 6.3 1.0 1.0 
30-34 5.2 8.7 0.6 1.7 
35-39 3.7 6.8 0.5 1.8 
40-44 4.3 3.8 1.1 0.9 
45-49 10.1 2.1 4.8 0.2 
50-54 9.6 2.6 3.7 0.3 
55-59 17.9 3.1 5.8 0.2 
60-64 13.3 2.7 4.9 0.2 
65-69 0 3.2 0.0 - 
70-74 0 3.7 0.0 - 
75-79 0 2.6 0.0 - 
80-85+ 0 2.3 0.0 - 
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Table 3.  
Average number of notifications and notification rates (NR) of cryptosporidiosis cases in 
each PHU from 2002-2012 by Aboriginal status. 
 
PHUs Aboriginal people Non-Aboriginal people 
Average no. of 
notifications 
(range) 
NR (per 
100,000) 
Average no. of 
notifications 
(range) 
NR (per 
100,000) 
Wheatbelt 1.6 (0-6) 44.9 6.9 (0-15) 9.7 
Goldfields 5.6 (2-17) 96.8 6.2 (0-18) 12.5 
Great Southern 0.36 (0-1) 17.1 5.2 (2-10) 9.3 
Kimberley 38.5 (12-59) 246.6 9.5 (4-22) 51.2 
Metropolitan 3.2 (0-9) 11.9 91.5 (9-319) 5.6 
Midwest 4.9 (0-14) 67.9 6.2 (0-25) 11.1 
Pilbara 11.3 (4-16) 151.8 5.5 (2-10) 13.9 
South West 1.0 (0-3) 31.7 12.4 (6-30) 8.4 
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Table 4.  
Cryptosporidium species and subtypes identified in Aboriginals and non-Aboriginals in WA. 
 Aboriginal Non-Aboriginal Unknown Total 
C. hominis 83 152 24 259 
IbA10G2 7 94 14 112 
IdA15G1 49 23 4 75 
IdA16 - 3 3 6 
IdA17 - 1 - 1 
IeA11G3T3 1 3 - 4 
IfA12G1 1 3 - 4 
IgA17 25 25 3 53 
C. parvum 2 42 10 54 
IIaA15G2R1 - 1 - 1 
IIaA17G2R1 - 9 - 10 
IIaA18G3R1 1 28 9 37 
IIaA19G4R1 1 1 1 3 
IIaA21G2R1 - 1 - 1 
IIdA15G1 - 1 - 1 
ND* - 1 - 1 
C. meleagridis - 11^ - 10 
Mink genotype - 1^ - 1 
Total 85 205 34 324 
*ND – subtype not determined. 
^Mixed infection – C. meleagridis and Cryptosporidium Mink genotype was identified from 
one case 
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Table 5. 
Distribution of C. hominis and C. parvum gp60 genotypes in remote, rural and metropolitan 
regions of WA by Aboriginality. 
 
  REMOTE RURAL METROPOLITAN 
  Aboriginal 
Non-
Aboriginal 
Aboriginal 
Non-
Aboriginal 
Aboriginal 
Non-
Aboriginal 
C. hominis       
IbA10G2 4 18 2 12 1 62 
IdA15G1 45 12 3 8 - 3 
IdA16 - - - 1 - 2 
IdA17 - - - - - 1 
IeA11G3T3 1 1 - 1 - 1 
IfA12G1 1 2 - - - 1 
IgA17 22 5 2 9 1 11 
C. parvum       
IIaA15G2R
1  
- - - 1 - - 
IIaA17G2R
1 
- 1 - 5 - 3 
IIaA18G3R
1 
- - 1 15 - 13 
IIaA19G4R
1  
1 - - 1 - - 
IIaA21G2R
1  
- - - 1 - - 
IIdA15G1  - - - - - 1 
Unknown - - - - - 1 
Total 74 39 8 54 2 99 
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Highlights 
 
 1st study to compare cryptosporidiosis in Aboriginal v non-Aboriginal communities 
 
 Notification rates among Aboriginal people were up to 50 times higher 
 
 Aboriginal people were mainly infected with the C. hominis IdA15G1 subtype 
 
 Non-Aboriginal people were predominantly infected with the IbA10G2 subtype 
 
 Unique endemicity of cryptosporidiosis in Aboriginal people 
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